OPTIC NEURITIS
Clinical trials for OPTIC NEURITIS explained in plain language.
Never miss a new study
Get alerted when new OPTIC NEURITIS trials appear
Sign up with your email to follow new studies for OPTIC NEURITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for optic nerve inflammation in early trial
Disease control Recruiting nowThis pilot study tests efgartigimod alfa, a drug that lowers certain antibodies, against a placebo in 20 adults experiencing their first episode of optic neuritis (inflammation of the optic nerve). All participants also receive standard steroid treatment. The goal is to see if th…
Matched conditions: OPTIC NEURITIS
Phase: PHASE2 • Sponsor: Anastasia Vishnevetsky, MD, MPH • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Could early plasma exchange save sight and mobility? new trial aims to find out
Disease control Recruiting nowThis study tests whether starting plasma exchange early, rather than waiting as a rescue option, leads to better vision in severe optic neuritis and better mobility in severe transverse myelitis. About 382 adults with these inflammatory nerve conditions will be randomly assigned …
Matched conditions: OPTIC NEURITIS
Phase: PHASE3 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
Allergy drug shows promise for rebuilding nerves in eye disease
Disease control Recruiting nowThis study tests whether clemastine fumarate, a common allergy medication, can help repair the protective coating around nerves in people with optic neuritis (inflammation of the optic nerve). About 90 participants will receive either clemastine or a placebo for 9 months. The goa…
Matched conditions: OPTIC NEURITIS
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 06, 2026 16:03 UTC